why this stock is massively overvalued.

Forbes Magazine has just recommended Thoratec as a cheap stock. It has 792employees and a market cap of US$531m. It leads the world in numerous heart products and is the leading innovator.
VCR has one still unproven product of little significance and one of many similar devices BUT IT HAS A MARKET CAP OF $340M.

What a joke. What a joke comparing its survival rate in 8 implants as a statistic against worldheart with 160 implants. What a joke comparing survival times when all companies only use these devices on the dying.

Meet Thoratec. Go to Yahoo.com and research it symbol THOR and learn why VCR is a Titanic.
Thoratec Corporation manufactures circulatory support products for use by patients with congestive heart failure. The Company's three major product groups are: circulatory support products, vascular graft products and point-of-care diagnostics. The circulatory support products include ventricular assist devices for the short-term and long-term treatment of congestive heart failure. Thoratec has also developed small diameter grafts using its proprietary materials to address the vascular access and coronary bypass surgery markets. The Company's grafts are sold in the United States and internationally for use in hemodialysis patients and are in clinical trials for coronary artery bypass applications. In addition, Thoratec supplies point-of-care blood diagnostics test systems that provide fast, accurate blood test results to improve patient management, reduce healthcare costs and improve patient outcomes.